Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Current Assets (2016 - 2023)

Historic Current Assets for Aptevo Therapeutics (APVO) over the last 9 years, with Q3 2023 value amounting to $21.1 million.

  • Aptevo Therapeutics' Current Assets fell 1418.47% to $21.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $21.1 million, marking a year-over-year decrease of 1418.47%. This contributed to the annual value of $27.4 million for FY2022, which is 4778.39% down from last year.
  • According to the latest figures from Q3 2023, Aptevo Therapeutics' Current Assets is $21.1 million, which was down 1418.47% from $22.7 million recorded in Q2 2023.
  • Over the past 5 years, Aptevo Therapeutics' Current Assets peaked at $65.8 million during Q2 2021, and registered a low of $10.5 million during Q2 2020.
  • Its 5-year average for Current Assets is $37.3 million, with a median of $31.4 million in 2022.
  • In the last 5 years, Aptevo Therapeutics' Current Assets tumbled by 7598.46% in 2020 and then surged by 52705.0% in 2021.
  • Aptevo Therapeutics' Current Assets (Quarter) stood at $30.0 million in 2019, then soared by 57.57% to $47.3 million in 2020, then rose by 11.23% to $52.6 million in 2021, then plummeted by 47.78% to $27.4 million in 2022, then fell by 23.04% to $21.1 million in 2023.
  • Its last three reported values are $21.1 million in Q3 2023, $22.7 million for Q2 2023, and $28.5 million during Q1 2023.